(medroxyprogesterone acetate injectable suspension, for intramuscular use)
Health Professional Information
Description
11 DESCRIPTION
Depo-Provera CI contains medroxyprogesterone acetate, a derivative of progesterone, as its active ingredient. Medroxyprogesterone acetate is active by the parenteral and oral routes of administration. It is a white to off‑white; odorless crystalline powder that is stable in air and that melts between 200°C and 210°C. It is freely soluble in chloroform, soluble in acetone and dioxane, sparingly soluble in alcohol and methanol, slightly soluble in ether, and insoluble in water.
The chemical name for medroxyprogesterone acetate is pregn-4-ene-3, 20-dione, 17-(acetyloxy)-6-methyl-, (6α-).
The structural formula is as follows:
Depo-Provera CI for IM injection is available in vials and prefilled syringes, each containing 1 mL of medroxyprogesterone acetate sterile aqueous suspension 150 mg/mL.
For Depo-Provera CI vials, each mL of sterile aqueous suspension contains: | |
Medroxyprogesterone acetate | 150 mg |
Polyethylene glycol 3350 | 28.9 mg |
Polysorbate 80 | 2.41 mg |
Sodium chloride | 8.68 mg |
Methylparaben | 1.37 mg |
Propylparaben | 0.150 mg |
Water for injection | quantity sufficient |
When necessary, pH is adjusted with sodium hydroxide or hydrochloric acid, or both. | |
For Depo-Provera CI prefilled syringes, each mL of sterile aqueous suspension contains: | |
Medroxyprogesterone acetate | 150 mg |
Polyethylene glycol 3350 | 28.5 mg |
Polysorbate 80 | 2.37 mg |
Sodium chloride | 8.56 mg |
Methylparaben | 1.35 mg |
Propylparaben | 0.147 mg |
Water for injection | quantity sufficient |
When necessary, pH is adjusted with sodium hydroxide or hydrochloric acid, or both. | |
Health Professional Information
{{section_name_patient}}
{{section_body_html_patient}}
Additional Resources
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine or vaccine.
Speak with a Pfizer Medical Information Professional regarding your Pfizer medicine or vaccine inquiry.
Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for a Pfizer medicine or a vaccine.
The submission will be reviewed during our standard business hours.
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this medication, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer medication, please call (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or by calling (800) 332-1088.